HOTH THERAPEUTICS INC (HOTH)
US44148G2049 - Common Stock
Full estimates are only available for subscribed users, you can see which data is available below.
Subscribed users also see more surprise data, now it is restricted to 4 quarters.
Examples of complete estimate data are available for MSFT and AAPL.
Registered users have access to more data. Please register or login for additional estimates and surprises .
| 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | N/A | N/A | N/A | N/A | N/A | N/A | N/A 50.06% | N/A 33.38% | ||||||||
| EBITDA YoY % growth | -1.87M | -2.5M -33.69% | -7.72M -208.80% | -7.3M 5.44% | -14.1M -93.15% | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | |
| EBIT YoY % growth | -1.87M | -2.5M -33.69% | -7.72M -208.80% | -7.3M 5.44% | -14.1M -93.15% | -11.07M 21.49% | -7.692M 30.51% | N/A -11.10% | N/A -56.95% | N/A -43.95% | N/A -19.51% | N/A -63.55% | N/A 244.86% | N/A 98.49% | N/A 54.00% | |
| Operating Margin | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | |
| EPS YoY % growth | N/A | N/A | N/A | -14.50 -7.97% | -16.50 -13.79% | -9.91 39.94% | -2.37 76.08% | N/A 45.34% | N/A 44.09% | N/A 12.68% | N/A | N/A | N/A | N/A | N/A |
All data in USD
| Q4 / 24 | Q1 / 25 | Q2 / 25 | Q3 / 25 | Q4 / 25 | |
|---|---|---|---|---|---|
| EPS Q2Q % growth | -0.31 2.78% | -0.26 44.57% | -0.26 -6.25% | -0.22 27.61% | -0.17 44.26% |
| Revenue Q2Q % growth | N/A | N/A | N/A | N/A | |
| EBITDA Q2Q % growth | N/A | N/A | N/A | N/A | N/A |
| EBIT Q2Q % growth | -2.614M -53.95% | N/A | N/A | N/A | N/A |
All data in USD
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q3 2024 Q2Q % growth | -0.31 48.33% | -0.35 | 0.04 | 10.61% |
| Q2 2024 Q2Q % growth | -0.24 57.89% | -0.44 | 0.20 | 45.28% |
| Q1 2024 Q2Q % growth | -0.46 47.73% | -0.44 | -0.02 | -4.88% |
| Q4 2023 Q2Q % growth | -0.32 88.81% | -0.52 | 0.20 | 38.49% |
| Q3 2023 Q2Q % growth | -0.60 70.73% | -0.74 | 0.14 | 18.86% |
| Q2 2023 Q2Q % growth | -0.57 74.67% | -1.18 | 0.61 | 51.83% |
| Q1 2023 Q2Q % growth | -0.88 68.00% | -0.88 | 0.00 | 0.26% |
| Q4 2022 Q2Q % growth | -2.86 18.29% | -2.34 | -0.52 | -22.44% |
| Q3 2022 Q2Q % growth | -2.05 41.43% | -2.44 | 0.39 | 16.08% |
| Q2 2022 Q2Q % growth | -2.25 35.71% | -2.42 | 0.17 | 7.12% |
| Q1 2022 Q2Q % growth | -2.75 54.17% | -3.57 | 0.82 | 22.97% |
| Q4 2021 Q2Q % growth | -3.50 -250.00% | -3.19 | -0.31 | -9.80% |
| Q3 2021 Q2Q % growth | -3.50 12.50% | -3.44 | -0.06 | -1.67% |
| Q2 2021 Q2Q % growth | -3.50 30.00% | -4.34 | 0.84 | 19.26% |
| Q1 2021 Q2Q % growth | -6.00 -33.33% | -2.55 | -3.45 | -135.29% |
| Q4 2020 Q2Q % growth | -1.00 90.48% | -2.55 | 1.55 | 60.78% |
| Q3 2020 Q2Q % growth | -4.00 5.88% | -3.44 | -0.56 | -16.19% |
| Q2 2020 Q2Q % growth | -5.00 -53.85% | -3.83 | -1.17 | -30.72% |
| Q1 2020 Q2Q % growth | -4.50 | -4.25 | -0.25 | -5.88% |
| Q4 2019 Q2Q % growth | -10.50 | -3.49 | -7.01 | -201.28% |
| Q3 2019 Q2Q % growth | -4.25 | -2.47 | -1.78 | -72.41% |
| Q2 2019 Q2Q % growth | -3.25 | -2.81 | -0.44 | -15.86% |
| Period | Reported | Estimate | Difference | Surprise |
|---|
| Next Q (1 month) | Next Q (3 month) | Next Year (1 month) | Next Year (3 month) | |
|---|---|---|---|---|
| EPS | 0% | 29.07% | 3.54% | 1.17% |
| Revenue | N/A | N/A | N/A | N/A |